Recalls
Cardinal Health tells customers to correct Presource kits with recalled infusion sets
Affected Presource kits should be corrected before continued use by removing and discarding the recalled infusion sets.

The FDA said Cardinal Health has told affected customers to correct Presource kits containing BD Alaris Pump Infusion Sets affected by an infusion-set recall before continued use. The correction does not require removing the kits from where they are used or sold, according to the FDA.
The FDA said customers should locate and quarantine affected kits, then attach a warning label telling clinicians to remove and discard the recalled infusion sets. The sets may cause unpredictable pump behavior, including under- or over-infusion or failure to infuse, which may lead to severe adverse events. The FDA said the outcomes may vary, especially for vulnerable patients such as neonates, children and critically ill patients. As of August 19, 2026, BD had reported no serious injuries or deaths associated with the issue. Cardinal Health sent affected customers a letter on September 24, 2026.


